PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) Operating cash flow 2016–2025
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$3.3MFY2025 · since FY2016: -$21.9M → -$3.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$3.3M | -1.3% |
| FY2024 | -$3.3M | -27.7% |
| FY2023 | -$2.6M | +15.4% |
| FY2022 | -$3.0M | -200.2% |
| FY2021 | -$1.0M | +75.2% |
| FY2020 | -$4.1M | +34.0% |
| FY2019 | -$6.2M | -18.9% |
| FY2018 | -$5.2M | +49.7% |
| FY2017 | -$10.3M | +52.8% |
| FY2016 | -$21.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice